IR Biosciences’ ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Research | PublicWire.com

February 8th, 2012

Halts
Issues

RSS Feed

Advancers

INBG 0.0007 600.0%
OOAG 0.057 29.25%
GETA 0.0642 15.46%
VSTNQ 1.40 3.68%
VTSS 0.317 16.90%
Decliners

GOIG 0.015 32.0%
CTDBQ 0.0099 11.50%
MINED 0.066 4.29%
SREH 0.006 53.85%
AMEL 0.98 1.00%
Market Trends

OTCBB Markets: 3,297,891,404

Pink Sheets Volume: 8,074,699,394

Advertise With Us!

Posted on 27. Jan, 2010 by PublicWire in Medical

IR Biosciences’ ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Research

IR Biosciences’ ImmuneRegen (OTCBB: IRBS) seems to be gathering quite a bit of attention from places like the NIH, the National Cancer Institute

Leave a Reply